The Federal Circuit recently held that makers of biosimilars must always notify brand-name rivals six months before commercial product launch. Brian Klock and Kathryn Easterling report.
08/03/2016 | Managing Intellectual Property Blog
Approval Biosimilar Notice Implicates Millions
1 min
Related Services
Related Insights
#NewYearNewCopyrightLaw: Mixed Reactions as Copyright Owners Ring in 2021 with the CASE Act
#NewYearNewCopyrightLaw: Mixed Reactions as Copyright Owners Ring in 2021 with the CASE Act
January 05, 2021
6min
The Leading “Not So Different” Podcast Episodes of 2020
The Leading “Not So Different” Podcast Episodes of 2020
December 31, 2020
1min
Opinion: The Year Ahead in Biosimilar Potential
Opinion: The Year Ahead in Biosimilar Potential
December 30, 2020
1min
Recent News
Corporate Secretary Quotes Belinda Vega on General Counsels’ Role in Complying with New Diversity Requirements
Corporate Secretary Quotes Belinda Vega on General Counsels’ Role in Complying with New Diversity Requirements
January 17, 2021
1min
DesignIntelligence Features Jamie Frankel on the Impact of COVID-19 on the New York City Development Community and Beyond
DesignIntelligence Features Jamie Frankel on the Impact of COVID-19 on the New York City Development Community and Beyond
January 14, 2021
1min
Financial Services Advocate Chris Scribner Joins Venable’s Legislative and Government Affairs Practice
Financial Services Advocate Chris Scribner Joins Venable’s Legislative and Government Affairs Practice
January 13, 2021
2min